MYC overexpression (≥40%) was noted in 73% of our cases, which is slightly lower that the frequency recently reported by Brunn et al. (92%) but still higher than that described in systemic DLBCL (approximately 30–50%) [9], [10], [12]. Here, MYC is linked to diffuse large B-cell lymphoma.